Larazotide Calculator
Also known as: AT-1001
Default: 5mg / 2mL / 0.5mgAdjust inputs to match your vial
About
What is Larazotide?
Larazotide is an octapeptide investigated for celiac disease and intestinal-barrier dysfunction. It is most often studied as an oral formulation; injectable use is uncommon and reference doses here are illustrative only.
Common vial sizes
| 5 mg | lyophilized powder |
Reference dose ranges
| 0.5 mg | ≈ 20 U-100 units (at 5mg / 2mL) |
| 1 mg | ≈ 40 U-100 units (at 5mg / 2mL) |
Reconstitution
How it's typically prepared
Larazotide is most often delivered orally. Reconstitution math may not apply to your formulation.
FAQ
Frequently asked questions
- Is larazotide approved?
- As of April 2026 larazotide is investigational; Phase 3 celiac trials did not meet primary endpoints.
Related
Other Healing peptides
Notice
PeptideDose is an educational reference. It is not medical advice and does not replace consultation with a licensed healthcare provider. Doses shown in presets are derived from published protocols and product labels — they are not personal recommendations.